Margaretta Colangelo

Insilico Medicine announced today that they have started the first human trial of ISM001-055 their AI-designed drug candidate for pulmonary fibrosis. This is a very significant milestone in the history of AI-powered drug discovery because this is the first time that a human being has been dosed with an AI-discovered novel molecule based on an …

Insilico Medicine Initiates Trial – Doses First Human With AI-Discovered Drug Read More »

Leucadia Therapeutics has developed AI algorithms that allow neuroscientists to analyze enormous datasets. This new approach incorporates cutting-edge deep learning applied to an advanced method for ultra-resolution contrast-enhanced micro-CT, a novel animal model, and a large clinical study designed to produce highly curated data for machine learning. For the past 25 years, Alzheimer’s disease researchers …

Scientists Develop AI Algorithms To Analyze Enormous Datasets In Alzheimer’s Research Read More »

This landmark approval of Paige Prostate by the FDA marks the beginning of a new era in the use of AI in pathology and paves the way for new innovations using AI in diagnostics. This week in a historic milestone, the FDA approved the first ever AI-based pathology product approved for clinical use. Paige Prostate is the first …

FDA Grants Approval For AI-Based Pathology Product For The First Time Read More »

Exciting new research from the AI Precision Health Institute at UH Cancer Center shows that deep learning can distinguish between mammograms of women who will develop breast cancer and those who will not. X-rays were first used to detect breast cancer in 1913. Although breast imaging has evolved, the fundamental information that radiologists use to …

Deep Learning Improves Prediction and Detection of Malignant Breast Cancer Read More »